Sponsored
Bharat Biotech in-licences GSK's Shigella vaccine candidate
Posted
Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.
Search
Categories
- National
- International
- Business
- Technology
- Health
- Education
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
11 sixes! DC flop Jake Fraser-McGurk lights up cricket in USA - Watch
Jake Fraser-McGurk's explosive 88 off 38 balls propelled San Francisco Unicorns to a formidable...
Mohanlal jokingly calls Mohan Babu a short-tempered person
Mohanlal and Vishnu Manchu were recently seen attending a promotional event for their upcoming...
Cooperative fraud case filed against Rabi Lamichhane and 28 others in Parsa
KATHMANDU: A case has been filed at the Parsa District Court against former Home Minister and...